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Summary A 69-year-old man with a history of paroxysmal atrial ﬁbrillation (PAF) and subse-
quent cerebral infarction was referred to our hospital because of an abnormal accumulation of
18F-ﬂuorodeoxyglucose (FDG) in the left atrial appendage (LAA) that was detected on positron
emission tomography-computed tomography (PET-CT) imaging during a health screening. Trans-
esophageal echocardiography (TEE) demonstrated thrombus formation in the LAA. Even after
the thrombus disappeared by strictly guided oral anticoagulant therapy, intense abnormal FDG
uptake in the LAA on PET-CT imaging persisted. In low-risk patients such as this, inﬂammationappendage;
Positron emission
tomography-
computed
may have played some role in LAA thrombus formation.
© 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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atomography;
Inﬂammation
ntroductionntra-atrial thrombus formation in patients with atrial ﬁb-
illation (AF) is known to be a potent risk factor for
hromboembolic events such as stroke. Thrombus formation
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oi:10.1016/j.jccase.2011.09.005s preferentially found in the left atrial appendage (LAA)
nd has been thought to be induced by blood stasis associ-
ted with AF. However, there is an apparent link between
hrombogenesis and inﬂammation [1].
CHADS2 (congestive heart failure, hypertension, age,
iabetes, stroke) score is a convenient and accurate clas-
iﬁcation for estimating stroke risk in patients who have
on-rheumatic AF [2]. In low-risk patients, the throm-
oembolic stroke risk can be as high as 1.5% per year
nd is associated with a 1.8-fold increase in mortality
2]. We report a case demonstrating a low stroke risk, in
Published by Elsevier Ltd. All rights reserved.
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oFigure 1 Serial 12-lead electrocardiograms at the time of st
months later (B). During sinus rhythm, P wave was biphasic in l
which 18F-ﬂuorodeoxyglucose (FDG) accumulation in the LAA
was detected on positron emission tomography-computed
tomography (PET-CT).
Case report
In July 2008, a 69-year-old man was admitted to our hospi-
tal because of cerebral infarction presenting with aphonia,
right hemiplegia, and paroxysmal atrial ﬁbrillation (PAF)
(Fig. 1A). He was started on medication with oral intake
of warfarin 3.5mg/day and pilsicainide 150mg/day. In
November 2008, he was re-admitted to our hospital because
an abnormal accumulation of FDG in the LAA was detected
on PET-CT imaging (Discovery LS, General Electric Medical
Systems, Waukesha, WI, USA) during health screening. PET-
CT was performed after fasting for at least 4 h and image
acquisition was initiated 50min after intravenous injection
of 185MBq of FDG. Whole-body emission scanning was per-
formed from the head to the inguinal region with 2min per
bed position (7—8 bed positions). A transmission scan with
CT for attenuation correction was performed prior to the
emission scan. Using emission and transmission scan data,
image reconstruction was performed and the reconstructed
images were converted to standardized uptake value (SUV)
image using the patient’s body weight and the injected dose
of FDG.
Laboratory examination showed prothrombin time-
international normalized ratio (PT-INR) 2.27 (normal
range < 1.14), brain natriuretic peptide (BNP) 177.4 pg/ml
(normal range <18 pg/ml), highly sensitive C-reactive pro-
tein (hs-CRP) 1.18mg/L, and D-dimer level 1.9g/ml
(normal range < 1.0). Twelve-lead electrocardiogram (ECG)
showed sinus rhythm and a biphasic P wave in lead V1
(Fig. 1B). The patient was diagnosed as having PAF because
of the ECG changes and frequent episodes of palpitation.
Health screening PET-CT showed accumulation of FDG in
the LAA (Fig. 2A and B) and the SUV was 3.4. Trans-
esophageal echocardiography (TEE) demonstrated thrombus
a
a
rshow atrial ﬁbrillation (A), which changed to sinus rhythm 5
1.
ormation in the LAA (Fig. 2C). The thrombus diameter was
2mm× 11mm, and the LAA ﬂow was 85 cm/s and 82 cm/s
>20). Therefore, oral anticoagulant therapy was increased
o warfarin 4.5mg/day under strict monitoring, and sinus
hythm was maintained with pilsicainide 150mg/day.
After strict anticoagulant therapy, the thrombus became
nclear and there was no tumor lesion detected on com-
uted tomography (Fig. 3A) Laboratory examination showed
T-INR 3.14, and the thrombus in the LAA disappeared on
EE (Fig. 3B). Health screening PET-CT was performed again
year 2 months later under the same conditions. Intense
bnormal FDG uptake in the LAA persisted on PET-CT imag-
ng (Fig. 3C), and the SUV was 4.76. Similarly this time, there
as no apparent thrombus in the LAA on TEE.
iscussion
e encountered a patient with PAF who showed intense
bnormal accumulation of FDG in the LAA, which remained
n PET-CT imaging even after the thrombus disappeared, by
trictly guided oral anticoagulant therapy.
A previous case report showed FDG uptake in the LAA in
atients with chronic AF [3], but on PET imaging alone. We
ad PET-CT, which helps to specify the LAA with more accu-
acy, also TEE, and follow-up PET-CT performed additionally.
lso in the present case, an intensive positive FDG uptake in
he LAA was recorded on PET-CT during a health screening,
o we had conﬁrmation on the patient’s history of PAF, and
lso any malignancy and thrombus were ruled out, and such
case was not reported previously.
FDG is a glucose analog that traces the transmembranous
ransport and hexokinase-mediated phosphorylation of glu-
ose, and deoxyglucose combines with glucose transporter
n inﬂammatory cells and malignant cells [4]. In previ-
us case reports, cardiac sarcoidosis or pericarditis showed
bnormal FDG uptake representing inﬂammatory activity,
part from its physiological uptake [5,6].
A recent report from the stroke prevention in atrial ﬁb-
illation (SPAF)-III study demonstrated that CRP positively
e34 K. Okura et al.
Figure 2 Positron emission tomography-computed tomography showed abnormal uptake in the left atrial appendage (LAA) (arrow),
and the standardized uptake value was 3.4 (A and B). Transesophageal echocardiography showed thrombus formation in the LAA
(C). LA, left atria.
Figure 3 Computed tomography of the chest (A) and transesophageal echocardiography (B) showing disappearance of thrombus in
the left atrial appendage (LAA). Positron emission tomography-computed tomography showed abnormal uptake in the LAA (arrow),
and the standardized uptake value was 4.76 (C).
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[Fluorodeoxyglucose accumulation in the left atrial appenda
correlated with stroke risk, related stroke risk factors, and
prognosis in 880 patients with AF [7]. In addition, a previous
study demonstrated that there is a possible link between
CRP and left atrial thrombus [1]. There are some reports
that active adhesion and recruitment of macrophages across
the endocardium occur in human ﬁbrillating atria suggesting
the presence of local immunologic inﬂammatory responses
around the atrial endocardium of AF [8]. Therefore, it is pos-
sible that some inﬂammatory alterations in the endocardium
may modulate the LAA endothelial function leading to a
thrombogenic status in patients with AF. We speculate that
inﬂammation may play some role in LAA thrombus formation
in this case.
Fujii et al. reported FDG uptake in the right atrial wall
in a patient with AF [9], and it was speculated that it was
due to an increased metabolism. It is known that thrombus
form in the LAA, and in the present case, an intensive pos-
itive FDG uptake was recorded on PET-CT in the LAA, not
in the right atrial wall. We also similarly speculate that the
increased accumulation of FDG was caused by an increased
metabolism, but more speciﬁcally an inﬂammatory mecha-
nism both in the LAA as in the right atrial wall.
CHADS2 score is an easy to use classiﬁcation scheme that
estimates the risk of stroke in elderly patients with AF.
CHADS2 score could facilitate risk stratiﬁcation and selec-
tion of antithrombotic therapy based on a patient-speciﬁc
risk of stroke [2]. Gage et al. suggested that by applying
a classiﬁcation scheme, clinicians could be able to iden-
tify AF patients who are at low risk for stroke even without
warfarin therapy. This patient had low risk of thrombus for-
mation with a CHADS2 score 0 before the referring stroke
in 2007. Despite anti-coagulation medication and normal
LAA ﬂow velocity, this patient demonstrated an enlarged
thrombus and an accumulation of FDG in the LAA in 2008.
Although PAF is a disease that can account for the forma-
tion of thrombus, the most remarkable feature of this case
was that there was an accumulation of FDG only in the LAA,
and that it persisted after the thrombus had disappeared by
anti-coagulation therapy.
The efﬁcacy of oral anticoagulant therapy in reducing
the risk of thromboembolic events has been demonstrated
in patients with AF. To optimize the intensity of anticoagula-
tion, as indicated by the INR, a target INR needs to achieve
the optimal balance between the prevention of thromboem-
bolic events and the occurrence of bleeding complications.
In this case, the INR value was effective. However, even
though the INR value was maintained within the range
recommended in the guidelines, we found that this case
became complicated by the LAA thrombus.
Our report emphasizes that, in case of an abnormal FDG
accumulation in the LAA found during a health screening, we
[a patient with paroxysmal atrial ﬁbrillation e35
hould examine not only by PET imaging but also by PET-CT,
o screen for thrombosis speciﬁcally in the LAA.
The presence of inﬂammation, as evident by FDG accu-
ulation, may also help to further stratify even low-risk
atients for LAA thrombus formation and possibly stroke and
eripheral embolism in non-rheumatic AF patients. PET-CT
ay be helpful for detecting inﬂammatory lesions related
o AF in low embolic risk patients. In patients with FDG
ccumulation in the LAA, strict anticoagulant therapy should
e administered. However, whether the local inﬂamma-
ion is a cause or a result of AF could not be determined
n this case and should be investigated in future stud-
es.
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